State of stem cell pools in experimental diabetes mellitus
✍ Scribed by E. D. Goldberg; A. M. Dygai; V. V. Zhdanov; G. N. Zyuz’kov; T. I. Fomina; L. A. Ermolaeva; L. A. Gur’yantseva; T. Yu. Khrichkova; T. V. Vetoshkina
- Publisher
- Springer US
- Year
- 2006
- Tongue
- English
- Weight
- 392 KB
- Volume
- 142
- Category
- Article
- ISSN
- 0007-4888
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Allograft (Allo) incorporation in the presence of a systemic disease like diabetes mellitus (DM) is becoming a major issue in the orthopedic community. Mesenchymal stem cells (MSC) are multipotent stem cells that may be derived from adult, whole bone marrow and have been shown to induce
It is generally accepted that hypertension and other vascular pathologies increase in diabetes mellitus (DM) patients as a result of the renin±angiotensin±aldosterone (RAA) system. In this study, changes in the renin-angiotensinaldosterone (RAA) system level was determined in Streptozotocin (STZ)-in
Pancreaticoduodenal (PD) allografts (Brown Norway-alloxan-diabetic rats, n = 190) were treated with cyclosporin A (Cy-A) 10 mg/kg/daily and compared with nondiabetics with Cy-A treatment (n = 55), diabetics (n = 50), and diabetics with Cy-A treatment (n = 45). Body weight, blood sugar, blood insulin